Intellego Technologies announced that Zhongyou Medical (Likang) will receive an exclusive market right to sell and market a certain type of Intellego`s UVC dosimeters and UVC devices in the healthcare sector in China. In exchange for the exclusive market right, Zhongyou Medical have committed to purchase products from Intellego to a minimum value of 16.2 million USD over a three-year period. Deliveries and payments will start immediately.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
37.30 SEK | +2.05% |
|
+5.67% | -9.02% |
Jan. 14 | Sweden's Intellego Technologies Signs Sales, Marketing Rights Deal in US | MT |
Jan. 14 | Intellego CEO Claes Lindahl increases his shareholding | FW |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
37.30SEK | +2.05% | +5.67% | 94.36M | ||
35.01CNY | +0.40% | -1.13% | 4.79B | ||
- Stock Market
- Equities
- INT Stock
- News Intellego Technologies AB
- Intellego China and Yuvio Sign Exclusive Distribution Agreement for the Chinese Healthcare Market to A Value of 16.2 Million